While it remains unclear how long Todd Blanche will stay in the job, whoever ends up taking over permanently will lead a ...
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results